Changes related to "Vincristine (Oncovin)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 21:25, 21 September 2018
   
Page name:

18 September 2018

 m   17:16  Glioblastoma‎ (diff | hist) . . (+1,273). . Jwarner (talk | contribs) (Radiation therapy {{#subobject:7dbd68|Regimen=1}})
 m   16:57  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+2,320). . Jwarner (talk | contribs) (Daunorubicin, L-Asparaginase, Vincristine, Prednisone {{#subobject:3c9897|Regimen=1}})
 m   11:10  Hodgkin lymphoma‎ (diff | hist) . . (+900). . Jwarner (talk | contribs)

17 September 2018

 m   22:14  Diffuse large B-cell lymphoma‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''")
     21:49  Hodgkin lymphoma‎ (diff | hist) . . (+3,047). . Jwarner (talk | contribs)
 m   15:35  Glioblastoma‎ (diff | hist) . . (+89). . Jwarner (talk | contribs) (Recurrent disease, non-curative salvage therapy)

16 September 2018

 m   21:43  Hodgkin lymphoma‎‎ (2 changes | history) . . (+687). . [Jwarner‎ (2×)]
 m    21:43 (cur | prev) . . (+1,953). . Jwarner (talk | contribs) (CBV, then auto HSCT {{#subobject:935235|Regimen=1}})
 m    21:37 (cur | prev) . . (-1,266). . Jwarner (talk | contribs) (BEAM, then auto HSCT {{#subobject:ed61ad|Regimen=1}})
 m   18:46  Follicular lymphoma‎ (diff | hist) . . (+198). . Jwarner (talk | contribs) (Ofatumumab monotherapy {{#subobject:a875bf|Regimen=1}})
 m   16:30  Soft tissue sarcoma‎ (diff | hist) . . (+582). . Jwarner (talk | contribs) (Docetaxel & Gemcitabine {{#subobject:1e718f|Regimen=1}})
 m   16:22  Small cell lung cancer‎ (diff | hist) . . (+1,200). . Jwarner (talk | contribs) (ACE {{#subobject:9fbf31|Regimen=1}})
 m   12:55  Penile cancer‎ (diff | hist) . . (0). . Jwarner (talk | contribs)
 m   12:46  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+129). . Jwarner (talk | contribs) (Idelalisib monotherapy {{#subobject:b872c5|Regimen=1}})
 m   11:28  CNS lymphoma‎ (diff | hist) . . (+63). . PeterYang (talk | contribs) (CYVE {{#subobject:b2c919|Regimen=1}}: correction of etoposide dose)
 m   09:41  Anaplastic glioma‎‎ (2 changes | history) . . (+1,447). . [Jwarner‎ (2×)]
 m    09:41 (cur | prev) . . (+24). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:44d48a|Regimen=1}})
 m    09:41 (cur | prev) . . (+1,423). . Jwarner (talk | contribs) (Irinotecan monotherapy {{#subobject:44d48a|Regimen=1}})

15 September 2018

 m   22:47  Hodgkin lymphoma‎‎ (2 changes | history) . . (-407). . [Jwarner‎ (2×)]
 m    22:47 (cur | prev) . . (-423). . Jwarner (talk | contribs) (References)
 m    22:40 (cur | prev) . . (+16). . Jwarner (talk | contribs) (References)
 m   11:46  Small cell lung cancer‎ (diff | hist) . . (+15). . Jwarner (talk | contribs) (Variant #2 {{#subobject:531cce|Variant=1}})